chlorthalidone

Ligand id: 7147

Name: chlorthalidone

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 2
Topological polar surface area 121.36
Molecular weight 338.01
XLogP 1.82
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
This is predominantly used as anti-hypertensive drug with diuretic action. It may be used alone or in combination with other anti-hypertensives. This drug may also be used to reduce oedema with specific aetiologies. There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
Mechanism Of Action and Pharmacodynamic Effects
Reduces water retention by inhibiting Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys by inhibiting the Na-Cl symporter, SLC12A3. This helps to reduce blood pressure. This mechanism of action tallies with the ChEMBL target for this drug. However, published interaction data indicates that this drug also appears to be an active inhibitor of several isoforms of carbonic anhydrases, with Kis ranging from 2.8-11000 nM [1].
External links